Plus Therapeutics financials at a glance

+ Portfolio

The revenue of Plus Therapeutics is reported as 0.00491 billion Dollars in the fiscal year 2023. The earnings were -4.24 Dollars per share in 2023, which was 63.29 higher than 2022. And about -0.01341 billion Dollars are reported as free cash flow in the financials of Plus Therapeutics 2023. No dividends were paid to the shareholders of the Plus Therapeutics stock NasdaqCM:PSTV in the financial year 2023.

$4.91M

Revenue

$-4.24

Earnings Per Share

-97.23%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

4.91

Earnings Per Share

-4.24

Gross Margin %

-97.23

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Rev.	Revenue	N/A	$4.91M	$0.22M	$0.00M	$0.30M	$7.00M	$6.65M	$6.41M	$11.38M	$11.66M	$7.60M	$12.20M	$8.71M	$7.98M	$8.25M	$5.84M	$6.85M	$5.26M	$0.00M
GM %	Gross Margin %	-,140.84%	-97.23%	0.00%	0.00%	0.00%	23.34%	-85.15%	-,102.71%	-61.40%	-90.29%	-,137.50%	-60.59%	-21.56%	-47.47%	-27.93%	76.96%	72.95%	93.02%	73.34%
OM	Operating Margin	0.00%	-,271.14%	0.00%	0.00%	0.00%	-52.26%	-,293.73%	-,296.32%	-,173.16%	-,196.88%	0.00%	-,266.05%	-,195.07%	0.00%	-,250.10%	-,121.47%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-5.88	$-4.24	$-11.55	$-16.32	$-25.27	$-41.55	$-1,282.50	$-4,875.00	$-9,600.00	$-21,420.00	$-53,693.99	$-49,274.99	$-61,874.99	$-68,624.99	$-67,499.99	$-60,749.99	$-,125,999.98	$-,140,624.98	$-,172,124.98
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0	-0.00%	-0.00%	0	0	0	0	0	0	0
Sha.	Shares	N/AM	4.28M	2.34M	1.48M	0.45M	0.26M	0.02M	0.07M	0.04M	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0M	0M	0M
OCF	Operating Cash Flow	N/A	$-12.85M	$-12.97M	$-10.28M	$-8.43M	$-5.91M	$-11.98M	$-18.13M	$-19.53M	$-20.47M	$-30.33M	$-34.56M	$-32.19M	$0.00M	$-23.57M	$0.00M	$0.00M	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$-13.41M	$-13.48M	$-10.42M	$-8.53M	$-5.98M	$-12.11M	$-19.62M	$-19.60M	$-21.08M	$-32.06M	$-35.08M	$-33.40M	$0.00M	$-24.18M	$0.00M	$0.00M	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$-5.17	$-4.14	$-7.84	$-0.86	$-2.02	$-4.32	$-69.65	$-,302.93	$-,566.77	$-1,127.52	$-2,908.88	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00

Plus Therapeutics financials at a glance

Financials

Discover